Heterocyclic compounds as NaV channel inhibitors and uses thereof

A compound of formula I,

• or a pharmaceutically acceptable salt thereof, wherein:
• Z1 is C(R)(R);
• Z2 is C(R)(R);
• X is —O— or —NRC(O)—;
• or X is absent;
• A is selected from the following groups:
• R1 is hydrogen;
• each of R2, R3, R4, and R5, is independently H or C1-6 aliphatic;
• Y is —CH2—;
• Ring B is phenyl;
• each R6 is independently —OR;
• m is 0, 1, 2, or 3;
• n is 0, 1, 2, or 3;
• q is 1, 2, or 3;
• r is 1;
• and
• each R is independently hydrogen or unsubstituted C1-6 aliphatic.